Impaired incretin secretion and pancreatic dysfunction with older age and diabetes

Metabolism: Clinical and Experimental

Volumn 63, Issue 7, 2014, Pages 922-929

  Geloneze, Bruno ^a,b   De Oliveira, Maria Da Saude ^a   Vasques, Ana Carolina Junqueira ^a   Novaes, Fernanda Satake ^a   Pareja, José Carlos ^a,b   Tambascia, Marcos Antonio ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b National Institute of Science and Technology on Obesity and Diabetes   (Brazil)

Author keywords

Beta cell function; GLP 1; Glucagon; Incretin; Insulin sensitivity

Indexed keywords

ADIPOCYTOKINE; ARGININE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN;

ABDOMINAL OBESITY; ADULT; AGED; AGING; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE TOLERANCE; GLYCEMIC INDEX; HOMA2 IR INDEX; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; MEAL; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PATIENT COUNSELING; PLASMA; POSTPRANDIAL STATE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; RATING SCALE; SENSITIVITY AND SPECIFICITY;

BETA-CELL FUNCTION; GLP-1; GLUCAGON; INCRETIN; INSULIN SENSITIVITY;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGED; AGING; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PANCREAS; POSTPRANDIAL PERIOD; UP-REGULATION;

EID: 84902546110     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.04.004     Document Type: Article

References (44)

1. K. Christensen, G. Doblhammer, R. Rau, and J.W. Vaupel Ageing populations: the challenges ahead Lancet 3 374 2009 1196 1208
2. F.P. Lu, K.P. Lin, and H.K. Kuo Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis PLoS One 4 2009 e4144
3. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
4. F. Ning, Q. Qiao, J. Tuomilehto, N. Hammar, S.Y. Ho, and S. Söderberg et al. Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev 26 2010 245 253
5. A.J. Scheen Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? Diabetes Metab 2005 [Spec No 2:5S27-5S34]
6. J.P. Palmer, and J.W. Ensinck Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients J Clin Endocrinol Metab 41 1975 498 503
7. A.M. Chang, and J.B. Halter Aging and insulin secretion Am J Physiol Endocrinol Metab 284 2003 E7 E12
8. P. Iozzo, H. Beck-Nielsen, M. Laakso, U. Smith, H. Yki-Jarvinen, and E. Ferrannini Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance J Clin Endocrinol Metab 84 1999 863 868
9. M. Stumvoll, C. Meyer, M. Kreider, G. Perriello, and J. Gerich Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans Metabolism 47 1998 1227 1232
10. J.G. McConnell, M.J. Alam, M.M. O'Hare, K.D. Buchanan, and R.W. Stout The effect of age and sex on the response of enteropancreatic polypeptides to oral glucose Age Ageing 12 1983 54 62
11. D. Elahi, D.K. Andersen, D.C. Muller, J.D. Tobin, J.C. Brown, and R. Andres The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus Diabetes 33 1984 950 957
12. C.G. MacIntosh, J.M. Andrews, K.L. Jones, J.M. Wishart, H.A. Morris, and J.B. Jansen et al. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility Am J Clin Nutr 69 1999 999 1006
13. L. Ranganath, I. Sedgwick, L. Morgan, J. Wright, and V. Marks The ageing entero-insular axis Diabetologia 41 1998 1309 1313
14. J. Korosi, C.H. McIntosh, R.A. Pederson, H.U. Demuth, J.F. Habener, and R. Gingerich et al. Effect of aging and diabetes on the enteroinsular axis J Gerontol A Biol Sci Med Sci 56 2001 M575 M579
15. G.S. Meneilly, A.S. Ryan, K.L. Minaker, and D. Elahi The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin J Clin Endocrinol Metab 83 1998 2925 2932
16. D. Elahi, M. McAloon-Dyke, N.K. Fukagawa, G.S. Meneilly, A.L. Sclater, and K.L. Minaker et al. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects Regul Pept 51 1994 63 74
17. American Diabetes Association Standards of medical care in diabetes - 2012 Diabetes Care 35 Suppl. 1 2012 S11 S63
18. The Oxford Centre for Diabetes Endocrinology & metabolism. Diabetes trial unit. HOMA calculator Available from: http://www.dtu.ox.ac.uk/ [Acessed Dec 2012]
19. A. Mari, G. Pacini, E. Murphy, B. Ludvik, and J.J. Nolan A model-based method for assessing insulin sensitivity from the oral glucose tolerance test Diabetes Care 24 2001 539 548
20. A. Mari, O. Schmitz, A. Gastaldelli, T. Oestrgaard, B. Nyholm, and E. Ferrannini Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects Am J Physiol Endocrinol Metab 283 2002 E1159 E1166
21. W.K. Ward, D.C. Bolgiano, B. McKnight, J.B. Halter, and D. Porte Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus J Clin Invest 74 1984 1318 1328
22. S.E. Kahn, R.L. Prigeon, D.K. McCulloch, E.J. Boyko, R.N. Bergman, and M.W. Schwartz et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function Diabetes 42 1993 1663 1672
23. E.S. Huang, J.Y. Liu, H.H. Moffet, P.M. John, and A.J. Karter Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study Diabetes Care 34 2011 1329 1336
24. J.B. Meigs, D.C. Muller, D.M. Nathan, D.R. Blake, and R. Andres The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging Diabetes 52 2003 1475 1484
25. M.E. Røder, R.S. Schwartz, R.L. Prigeon, and S.E. Kahn Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels J Clin Endocrinol Metab 85 2000 2275 2280
26. G.S. Meneilly, and T. Eliott Assessment of insulin sensitivity in older adults using the hyperglycemic clamp technique J Am Geriatr Soc 46 1998 88 91
27. G. Radegran, E. Blomstrand, and B. Saltin Peak muscle perfusion and oxygen uptake in humans: importance of precise estimates of muscle mass J Appl Physiol 87 1999 2375 2380
28. E. Ferrannini, S. Vichi, H. Beck-Nielsen, M. Laakso, G. Paolisso, and U. Smith Insulin action and age. European Group for the Study of Insulin Resistance (EGIR) Diabetes 45 1996 947 953
29. P.J. Coon, E.M. Rogus, D. Drinkwater, D.C. Muller, and A.P. Goldberg Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age J Clin Endocrinol Metab 75 1992 1125 1132
30. R.S. Ahima Connecting obesity, aging and diabetes Nat Med 15 2009 996 997
31. S.E. Kahn The relative contributions of insulin resistance and beta-cell dysfunction to the physiopathology of type 2 diabetes Diabetologia 46 2003 3 19
32. C.C. Jensen, M. Cnop, R.L. Hull, W.Y. Fujimoto, S.E. Kahn, and American Diabetes Association GENNID Study Group Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S Diabetes 51 2002 2170 2178
33. A. Fritsche, A. Madaus, N. Stefan, O. Tschritter, E. Maerker, and A. Teigeler et al. Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans Diabetes 51 Suppl. 1 2002 S234 S239
34. A. Lund, T. Vilsbøll, J.I. Bagger, J.J. Holst, and F.K. Knop The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes Am J Physiol Endocrinol Metab 300 2011 E1038 E1046
35. I. Vardarli, L.D. Köthe, J.J. Holst, C.F. Deacon, M. Theodorakis, and J.J. Meier et al. GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes. Mentis N Diabetes 60 2011 1270 1276
36. F.C. Lynn, N. Pamir, E.H. Ng, C.H. McIntosh, T.J. Kieffer, and R.A. Pederson Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats Diabetes 50 2001 1004 1011
37. I. Pernicova, and M. Korbonitz Metformin - mode of action and clinical implications for diabetes and cancer Nat Rev Endocrinol 10 2014 143 156
38. M. Stumvoll, N. Nurjhan, G. Perriello, G. Dailey, and J.E. Gerich Metabolic effects of metformin in non-insulin-dependet diabetes mellitus N Engl J Med 333 1995 550 554
39. S.K. Thondam, A. Cross, D.J. Cuthbertson, J.P. Wilding, and C. Daousi Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with type 2 diabetes mellitus Diabet Med 29 2012 e205 e210
40. C. Solis-Herrera, C. Triplitt, J.J. Garduno-Garcia, J. Adams, R.A. DeFronzo, and E. Cerosimo Mehcanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes Diabetes Care 36 2013 2756 2762
41. J.R. Lindsay, N.A. Duffy, A.M. McKillop, J. Ardill, F.P.M. ÓHarte, and P.R. Flatt Inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes Diabet Med 22 2005 654 657
42. J. Cuthbertson, S. Patterson, F.P.M. ÓHarte, and P.M. Bell Investigation of the effect of oral metformin in dipeptidylpeptidase-4 (DPP-4) activity in type 2 diabetes Diabet Med 26 2009 649 654
43. S.K. Inouye, S. Studenski, M.E. Tinetti, and G.A. Kuchel Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept J Am Geriatr Soc 55 2007 780 791
44. Diabetes Prevention Program Research Group, W.C. Knowler, S.E. Fowler, R.F. Hamman, C.A. Christophi, and H.J. Hoffman et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 374 2009 1677 1686